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Abstract. The n-3 fatty acids, eicosapentaenoic acid (EPA) 
and docosahexaenoic acid (DHA), found in fish oil, exert a 
number of beneficial effects, and they are used in the treatment 
of hyperlipidemia. In recent years, EPA and DHA have been 
found to affect cancer cell proliferation. In the present study, 
PC3 cells, which are androgen‑independent prostate cancer 
cells that resemble castration‑resistant prostate cancer cells, 
were used to investigate a possible novel treatment for castra-
tion‑resistant prostate cancer. The PC3 cells were cultured and 
incubated with various concentrations of EPA or DHA. Cancer 
proliferation was confirmed by trypan blue microscopy. 
Invasion and migration assays were used in the upper chamber 
in PC3 cells, and serum‑free medium and various concentra-
tions of EPA or DHA were placed in the lower chamber in 
serum‑containing medium. EPA and DHA decreased PC3 
cell proliferation, invasion and migration. The effect of EPA 
on PC3 cells was dose‑dependent and significant differences 
were observed at concentrations of 100 and 200 µg/ml. The 
effect of DHA on PC3 cells was similar to that of EPA. In the 
migration assay, EPA exerted almost no effects at 25 µg/ml, 
but migration was reduced at 50 µg/ml. Similar to EPA, DHA 
exerted almost no effects at 25 µg/ml, but further reduction 
was observed at the 50 µg/ml concentration. In the invasion 
assay, EPA at 25 µg/ml was not significantly different from the 
control, but suppressed invasion at 50 µg/ml. DHA decreased 
invasion compared with the control at 25 µg/ml, whereas 
invasion was significantly reduced at a DHA concentration of 
50 µg/ml. In conclusion, it was demonstrated that EPA and 
DHA were effective in decreasing the proliferation, inva-
sion and migration of prostate PC3 cancer cells. However, 
the detailed underlying mechanisms have not yet been fully 
elucidated.
Introduction
Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) 
are n‑3 fatty acids that have several beneficial effects, including 
decreasing the plasma triglyceride concentration, lipoprotein 
metabolism (1,2), inhibiting platelet aggregation by collagen (3), 
and improving the reduced elasticity of the arterial walls through 
the endothelium‑dependent relaxation response in rabbits (4). 
For these reasons, DHA and EPA are clinically used in Japan. 
In recent years, n‑3 fatty acids have been shown to decrease the 
proliferation of cancer cells in colon, breast and liver cancer, as 
well as neuroblastoma. In addition, n‑3 fatty acids may be used in 
cancer cachexia; the combination of chemotherapy and n‑3 fatty 
acids was helpful in the curative as well as the palliative clinical 
setting (5), but a systematic review did not evaluate the balance 
of their cost‑effectiveness against their utility (6). A number of 
studies have investigated cancer cell growth; however, only a 
limited number of studies have examined invasion and metas-
tasis in prostate cancer, which exhibits an increasing prevalence. 
In the present study, the PC3 prostate cancer cell line was used, 
which is an androgen‑independent human prostate cancer cell 
line that is similar to castration‑resistant prostate cancer. A 
common metastatic organ in prostate cancer is bone, and the 
PC3 cell line was derived from a bone‑metastatic prostate cancer 
patient. Therefore, the aim of the present study was to determine 
whether EPA and DHA inhibit the proliferation, invasion and 
migration of PC3 cells, in order to explore a possible novel 
method for the treatment of castration‑resistant prostate cancer.
Materials and methods
Proliferation. PC3 cells were grown in RPMI‑1640 culture 
medium (Wako, Tokyo, Japan) supplemented with 5% 
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heat‑inactivated fetal bovine serum (FBS), 100 U/ml peni-
cillin and 100 µg/ml streptomycin (Wako). The cells were 
washed twice with phosphate‑buffered saline (PBS; Wako) and 
serum‑free RPMI‑1640 containing 25, 50, 100, and 200 µg/ml 
EPA or DHA solution. Trypsin was added 24 h later, and an 
equal volume of trypan blue was added. The cell number was 
determined using light microscopy and a hemocytometer.
Migration and invasion assay. The migration and invasion 
assays were performed with Transwell membranes (pore size, 
8 μm; Falcon, Tokyo, Japan) coated with Matrigel™ matrix 
basement membrane (invasion assay), or without coating 
(migration assay). The cells (2x105) were suspended in the upper 
chamber of the Transwell inserts. The medium of the upper 
chamber was serum‑free RPMI‑1640 containing different 
concentrations of EPA or DHA. RPMI‑1640 containing 10% 
FBS was used as chemoattractant in the lower chamber. At 
24 or 48 h after incubation, the cells were washed with PBS 
twice and cells on the upper chambers were removed with a 
cotton swab soaked in PBS. Migrating or invading cells were 
fixed with 100% methanol and stained with 0.1% crystal violet 
solution. Migrating or invading cells in four randomly selected 
fields on the underside of the inserts were counted under a 
light microscope.
Reagent and cell culture. EPA and DHA (Sigma‑Aldrich, St. 
Louis, MO, USA) were dissolved in 99% isopropanol. The 
desired concentration was reached by dilution in serum‑free 
medium with 3% BSA. This solution was used for all studies. 
PC3 cells were cultured in RPMI‑1640 medium in a 10‑cm dish. 
When the cells were 70‑80% confluent, they were passaged. 
After this step, the medium was changed at 24 and 48 h.
Results
Effects of DHA and EPA on PC3 cell proliferation. EPA and 
DHA decreased PC3 cell proliferation. The effect of EPA on 
PC3 cells was dose‑dependent and significant differences were 
observed at concentrations of 100 and 200 µg/ml. The effect of 
DHA on PC3 cells was also significant at 100 and 200 µg/ml 
(Fig. 1). As seen in the photomicrographs of untreated and 
treated PC‑3 cells, the number of surviving cells decreased 
gradually in response to the increasing concentrations of EPA 
and DHA (Fig. 2).
Effects of EPA and DHA on PC3 cell migration and invasion. 
EPA and DHA inhibited the invasion (Fig. 3) and migra-
tion (Fig. 4) of PC3 cells. In the invasion assay, EPA did not 
significantly inhibit invasion at a concentration of 25 µg/ml 
compared with the control, but significantly suppressed inva-
sion at 50 µg/ml. Invasion was significantly reduced at a DHA 
concentration of 25 and 50 µg/ml. In the migration assay, 
DHA and EPA exerted almost identical effects at 25 µg/ml, but 
further reduction of cell migration was observed at a concen-
tration of 50 µg/ml.
Discussion
The results of the present study demonstrated that EPA and 
DHA exert a potent effect on cancer cells. EPA and DHA 
decreased the proliferation, invasion and migration in the PC3 
prostate cancer cell line. Previous studies on this subject have 
used DU145, an androgen‑independent prostate cancer cell line, 
obtained from brain metastasis of prostate cancer. It has been 
demonstrated the inhibitory effects of n‑3 fatty acids on prostate 
cancer cells in culture suggest interference with growth factor 
signaling (7). It was also reported that LNCaP cell growth was 
inhibited by EPA and DHA (8). The effect of EPA and DHA 
on the proliferation and invasion of the breast cancer cell lines 
MDA‑MB‑231 and MDA‑231 Luc and the effect of EPA and 
DHA on breast cancer metastasis to bone following intracar-
diac injection of MDA‑MB‑231 and MDA‑231‑Luc cells was 
also evaluated in other studies (9,10). In brief, MDA‑MB‑231 
cells were injected into mice that were fed experimental diets 
containing EPA or DHA. It was concluded that DHA inhibited 
the proliferation of cancer cells in bone metastasis compared 
with EPA (9). It was also demonstrated that there is an asso-
ciation between PC3 cell invasion and voltage‑gated sodium 
channels; the data suggested that EPA inhibited the sodium 
current and downregulated sodium channel function (10).
As mentioned above, a study involving the DU145 pros-
tate cancer cell line demonstrated that EPA decreased cell 
proliferation, the effect of DHA on proliferation did not 
differ significantly from the control (7). However, another 
study reported that EPA and DHA induced dose‑dependent 
decreases in PC3 cell proliferation and the effects were similar 
between EPA and DHA (11).
In HT29 and HT29‑dx colon cancer cells, omega‑3 fatty 
acids inhibited cholesterol synthesis through ubitiquination 
Figure 1. Effect of DHA (top panel) and EPA (bottom panel) on PC3 cell 
proliferation. At 24 h after seeding, various concentrations of DHA and EPA 
(25, 50, 100 and 200 μg/ml) were added, with untreated cells as the control 
and 3% BSA/Iso as the negative control. *P<0.05 and **P<0.01 vs. control 
PC3 cells. EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid; Iso, 
isopropanol; BSA, bovine serum albumin.
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of HMG‑CoA reductase. The inhibition of HT29 cell prolif-
eration and cholesterol synthesis was correlated with cell 
viability (12).
The addition of EPA, DHA and α‑linoleic acid has been 
shown to decrease proliferation in neuroblastoma IMR‑32 
cells in a study investigating the effect of eicosanoids, such 
as lipoxin A4, prostaglandin and leukotriene, on IMR‑32 
cells (13).
A study involving HepG2 cells and normal human liver 
L‑02 cells demonstrated that HepG2 cell proliferation 
decreased dose‑dependently with EPA treatment. The effect 
was not different between incubation times of 24 and 48 h, 
but L‑02 cell proliferation was not affected by EPA. In 
addition, the study reported that EPA induced the degrada-
tion of pro‑caspase‑9 and pro‑caspase‑3 in HepG2 cells, 
through induction of MPTP and release of cytochrome C 
Figure 2. Photomicrographs of untreated and treated PC‑3 cells. The number of surviving cells decreased gradually in response to the increasing concentra-
tions of EPA and DHA. Control, untreated cells; EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid.
Figure 3. Effect of DHA (top panel) and EPA (bottom panel) on PC3 cell 
invasion. PC3 cells were seeded with Matrigel coating in the upper chamber 
and incubated with various concentrations of DHA or EPA (25 and 50 μg/ml) 
with 10% fetal bovine serum‑supplemented medium in the lower chamber. 
After 40 h, the number of invading cells was counted. Data are presented 
as mean ± standard error (data from 3 different experiments). *P<0.05 and 
**P<0.01 vs. control PC3 cells. EPA, eicosapentaenoic acid; DHA, docosa-
hexaenoic acid.
Figure 4. Effect of DHA (top panel) and EPA (bottom panel) on PC3 cell 
migration. PC3 cells were seeded in the upper chamber and incubated with 
various concentrations of DHA or EPA (25 and 50 μg/ml) with 10% fetal 
bovine serum‑supplemented medium in the lower chamber. After 24 h, the 
number of migrating cells was counted. Data are presented as mean ± standard 
error (data from 3 different experiments). *P<0.05 and **P<0.01 vs. control 
PC3 cells. EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid.
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from the mitochondria to the cytoplasm in a time‑dependent 
manner (14).
Those studies demonstrated that EPA and DHA decreased 
cancer cell proliferation. EPA and DHA exerted a number of 
effects, including changes in intracellular ion concentration, 
ubiquitination, and the inhibition of multidrug resistance 
proteins. Our results demonstrated that EPA decreased cancer 
proliferation more efficiently compared with DHA, suggesting 
a possible treatment for metastatic castration‑resistant 
prostate cancer. In addition, PC3 cells expressed phos-
phoinositide 3 kinase (PI3K)/AKT‑related PIP5K1α (15), 
and HBx transfection in HepG2 cells led to the expression 
of nuclear factor (NF)‑κβ (16). NF‑κβ is downstream of 
PI3K/AKT and is a transcription factor that acts on a variety of 
genes. However, those studies did not demonstrate the effects 
of EPA and DHA, although EPA and DHA were shown to 
inhibit NF-κβ (17,18). Therefore, similar effects may also be 
expected in PC3 cells, although the underlying mechanisms in 
PC3 cells require further elucidation.
In conclusion, EPA and DHA inhibited invasion and 
migration as well as proliferation of PC‑3 cells. Furthermore, 
it has been demonstrated that EPA and DHA exerted indepen-
dent effects on decreasing the proliferation and invasion of 
prostate PC3 cancer cells. However, the detailed underlying 
mechanisms have not yet been fully elucidated.
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